메뉴 건너뛰기




Volumn 244, Issue 1-2, 2000, Pages 59-67

Identification of HLA-A*03, A*11 and B*07-restricted melanoma-associated peptides that are immunogenic in vivo by vaccine-induced immune response (VIIR) analysis

Author keywords

CD8+ T cells; ELISPOT; Melanoma vaccine; Peptide; T cell epitope

Indexed keywords

EPITOPE; HLA A ANTIGEN; MELANOMA VACCINE; PEPTIDE; CANCER VACCINE; HLA A11; HLA A3 ANTIGEN; HLA ANTIGEN; HLA B7 ANTIGEN; HLA-A11; MAGEA3 PROTEIN, HUMAN; MART1 ANTIGEN; MELANOCYTE LINEAGE SPECIFIC ANTIGEN GP100; MELANOCYTE LINEAGE-SPECIFIC ANTIGEN GP100; MEMBRANE PROTEIN; MONOPHENOL MONOOXYGENASE; PEPTIDE FRAGMENT; POLYVALENT MELANOMA CELL VACCINE; TUMOR ANTIGEN; TUMOR PROTEIN;

EID: 0034692682     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(00)00254-4     Document Type: Article
Times cited : (24)

References (22)
  • 2
    • 0003138969 scopus 로고
    • Partially purified tumor antigens
    • DeVita V.T., Hellman S., Rosenberg S.A. (Eds.), Biologic Therapy of Cancer, 2nd Edition, Philadelphia, PA: J.B. Lippincott
    • (1995) , pp. 668
    • Bystryn, J.C.1    Shapiro, R.L.2    Oratz, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.